Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | NVL-330 |
Trade Name | |
Synonyms | NVL330|NVL 330 |
Drug Descriptions |
NVL-330 is a brain-penetrant inhibitor of wild-type and mutant ERBB2 (HER2), including exon 20 insertions, which reduces downstream signaling and potentially decreases tumor growth (Cancer Res (2024) 84 (6_Supplement): 1979). |
DrugClasses | HER2 Inhibitor 42 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
NVL-330 | NVL-330 | 0 | 1 |